Madryn Asset Management
Description
Madryn Asset Management is a New York-based alternative asset management firm with a specialized focus on the global healthcare sector. The firm primarily invests in commercial-stage and late-stage development life sciences companies, offering customized financing solutions that include debt, structured equity, and royalty financings. Madryn aims to provide flexible capital to companies that require non-dilutive or minimally dilutive funding to advance their products, expand commercialization efforts, or manage their balance sheets. Their investment strategy is centered on identifying companies with strong clinical data, clear regulatory pathways, and significant market potential, often targeting those with established revenue streams or near-term commercialization prospects.
Investor Profile
Madryn Asset Management has backed more than 28 startups, with 2 new investments in the last 12 months alone. The firm has led 18 rounds, about 64% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Debt, Series Unknown, Debt Financing rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Medical, Therapeutics.
- Led 2 rounds in the past year.
- Typical check size: $25M – $150M.
Stage Focus
- Post Ipo Debt (43%)
- Series Unknown (14%)
- Debt Financing (11%)
- Post Ipo Equity (11%)
- Private Equity (7%)
- Series D (4%)
- Series A (4%)
- Convertible Note (4%)
- Series E (4%)
Country Focus
- United States (89%)
- Canada (11%)
Industry Focus
- Health Care
- Medical
- Therapeutics
- Neuroscience
- Psychology
- Medical Device
- Biotechnology
- Wellness
- Pharmaceutical
- Beauty
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
